|
KMID : 1143120200100030029
|
|
Asia Pacific Allergy
2020 Volume.10 No. 3 p.29 ~ p.29
|
|
|
Tolerability to paracetamol and preferential COX-2 inhibitors in patients with cross-reactive nonsteroidal anti-inflammatory drugs hypersensitivity
|
|
Terzioglu Kadriye
Sancar Ozgur
Ekerbicer Hasan Cetin
Ozturk Raziye Tulumen
Epozturk Kursat
|
|
|
Abstract
|
|
|
Background: Acetylsalicylic acid/aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used drugs that may cause hypersensitivity reactions in a substantial proportion of patients. Physicians ought to be aware of these situations.
Objective: We aimed to present the clinical characteristics and rates of tolerability to cyclooxygenase (COX)-2 inhibitor analgesics in patients who had admitted due to multiple cross-reactive type of NSAID hypersensitivity.
Methods: The files of the patients who had admitted with multiple NSAIDs-induced symptoms were investigated retrospectively. Age, sex, underlying diseases, clinical manifestation, skin test results, and drug provocation test results were analyzed.
Results: In 105 patients with multiple cross-reactive type of NSAID hypersensitivity, we found the rate of cross-reactivity to any of the relatively safe alternatives including paracetamol, meloxicam, and nimesulide to be 16.1%. The rate of cross-reactivity to these relatively safe drugs was significantly higher in patients with a history of anaphylaxis induced by NSAID intake (p = 0.006).
Conclusion: The diagnosis of COX-1-mediated multiple NSAID hypersensitivity can be often established with a detailed history. Although rare, severe hypersensitivity reactions may be observed in these patients. Undesired situations for both patients and physicians may be avoided by testing relatively safe paracetamol and COX-2 inhibitors in experienced centers.
|
|
|
KEYWORD
|
|
|
Cyclooxygenase-2 inhibitors, Hypersensitivity, Nonnarcotic analgesics, Nonsteroidal anti-inflammatory agents, Paracetamol
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|